| 0 |
SOFT TISSUE SWELLING |
16 |
0.0282 |
| 1 |
SOFT TISSUE DISORDER |
23 |
0.0207 |
| 2 |
LYMPHADENITIS |
29 |
0.0120 |
| 3 |
CD19 LYMPHOCYTES DECREASED |
1 |
0.0077 |
| 4 |
PNEUMONIA VIRAL |
24 |
0.0075 |
| 5 |
HEART RATE ABNORMAL |
40 |
0.0072 |
| 6 |
BURNOUT SYNDROME |
3 |
0.0053 |
| 7 |
BLOOD MAGNESIUM DECREASED |
40 |
0.0046 |
| 8 |
LYMPH NODE PAIN |
6 |
0.0032 |
| 9 |
ARTHRITIS ENTEROPATHIC |
1 |
0.0031 |
| 10 |
C-REACTIVE PROTEIN ABNORMAL |
17 |
0.0026 |
| 11 |
SEXUAL ABUSE |
1 |
0.0023 |
| 12 |
MENTAL FATIGUE |
3 |
0.0020 |
| 13 |
CLOSTRIDIUM DIFFICILE INFECTION |
40 |
0.0018 |
| 14 |
TENDERNESS |
19 |
0.0018 |
| 15 |
MUSCLE TWITCHING |
40 |
0.0017 |
| 16 |
SYNOVITIS |
29 |
0.0016 |
| 17 |
DYSBIOSIS |
1 |
0.0012 |
| 18 |
FIBROMYALGIA |
27 |
0.0011 |
| 19 |
ORAL PAIN |
22 |
0.0010 |
| 20 |
LIVER FUNCTION TEST ABNORMAL |
27 |
0.0009 |
| 21 |
PRODUCTIVE COUGH |
44 |
0.0009 |
| 22 |
CHRONIC GASTRITIS |
2 |
0.0009 |
| 23 |
LYMPHADENOPATHY |
29 |
0.0008 |
| 24 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
2 |
0.0008 |
| 25 |
DUODENAL ULCER HAEMORRHAGE |
2 |
0.0007 |
| 26 |
LOSS OF EMPLOYMENT |
2 |
0.0007 |
| 27 |
INTESTINAL POLYP |
1 |
0.0006 |
| 28 |
FEBRILE NEUTROPENIA |
40 |
0.0006 |
| 29 |
BLOOD CHOLESTEROL INCREASED |
27 |
0.0006 |
| 30 |
SERUM FERRITIN DECREASED |
1 |
0.0006 |
| 31 |
MUSCLE SPASTICITY |
7 |
0.0006 |
| 32 |
LEUKOPENIA |
28 |
0.0006 |
| 33 |
HYPOPROTEINAEMIA |
1 |
0.0005 |
| 34 |
SKIN ATROPHY |
3 |
0.0005 |
| 35 |
THROMBOSIS |
40 |
0.0005 |
| 36 |
INFECTION |
70 |
0.0005 |
| 37 |
HERPES ZOSTER |
27 |
0.0005 |
| 38 |
C-REACTIVE PROTEIN INCREASED |
17 |
0.0005 |
| 39 |
EAR PAIN |
9 |
0.0005 |
| 40 |
BODY TEMPERATURE INCREASED |
9 |
0.0004 |
| 41 |
EAR DISORDER |
2 |
0.0004 |
| 42 |
CONTRAINDICATED PRODUCT ADMINISTERED |
13 |
0.0004 |
| 43 |
WHITE BLOOD CELL COUNT DECREASED |
45 |
0.0004 |
| 44 |
BLOOD PRESSURE DIASTOLIC DECREASED |
3 |
0.0004 |
| 45 |
CEREBRAL DISORDER |
3 |
0.0004 |
| 46 |
PLATELET COUNT DECREASED |
43 |
0.0004 |
| 47 |
ARTHRITIS |
30 |
0.0004 |
| 48 |
MUSCLE DISORDER |
3 |
0.0004 |
| 49 |
EOSINOPHILIC OESOPHAGITIS |
1 |
0.0004 |
| 50 |
OESOPHAGEAL STENOSIS |
1 |
0.0004 |
| 51 |
BRAIN NEOPLASM |
3 |
0.0003 |
| 52 |
NEOPLASM PROGRESSION |
11 |
0.0003 |
| 53 |
STOMATITIS |
19 |
0.0003 |
| 54 |
WALKING AID USER |
2 |
0.0003 |
| 55 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
21 |
0.0003 |
| 56 |
REGURGITATION |
1 |
0.0003 |
| 57 |
NERVE INJURY |
3 |
0.0003 |
| 58 |
SWELLING |
23 |
0.0002 |
| 59 |
JOINT SWELLING |
29 |
0.0002 |
| 60 |
DISEASE PROGRESSION |
28 |
0.0002 |
| 61 |
RESPIRATORY DISORDER |
7 |
0.0002 |
| 62 |
NIGHT SWEATS |
7 |
0.0002 |
| 63 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
10 |
0.0002 |
| 64 |
HYPOTENSION |
40 |
0.0002 |
| 65 |
DRUG INTOLERANCE |
19 |
0.0002 |
| 66 |
PERIPHERAL SWELLING |
30 |
0.0002 |
| 67 |
POOR VENOUS ACCESS |
2 |
0.0002 |
| 68 |
IRRITABLE BOWEL SYNDROME |
4 |
0.0002 |
| 69 |
PERICARDITIS |
3 |
0.0002 |
| 70 |
ACCIDENT |
2 |
0.0002 |
| 71 |
HYPERLIPIDAEMIA |
2 |
0.0002 |
| 72 |
RHEUMATOID ARTHRITIS |
19 |
0.0002 |
| 73 |
ARTHRALGIA |
65 |
0.0002 |
| 74 |
LOWER RESPIRATORY TRACT INFECTION |
7 |
0.0002 |
| 75 |
SINUS CONGESTION |
2 |
0.0001 |
| 76 |
ANAEMIA |
28 |
0.0001 |
| 77 |
MASS |
2 |
0.0001 |
| 78 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 79 |
GINGIVAL PAIN |
1 |
0.0001 |
| 80 |
WEIGHT DECREASED |
29 |
0.0001 |
| 81 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 82 |
URINARY INCONTINENCE |
3 |
0.0001 |
| 83 |
DISABILITY |
2 |
0.0001 |
| 84 |
HEAD INJURY |
3 |
0.0001 |
| 85 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 86 |
SKIN DISORDER |
3 |
0.0001 |
| 87 |
SNEEZING |
2 |
0.0001 |
| 88 |
BONE PAIN |
5 |
0.0001 |
| 89 |
PRODUCT USE ISSUE |
16 |
0.0001 |
| 90 |
PRODUCT TASTE ABNORMAL |
1 |
0.0001 |
| 91 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 92 |
SINUSITIS |
7 |
0.0001 |
| 93 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
3 |
0.0001 |
| 94 |
URTICARIA |
11 |
0.0001 |
| 95 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 96 |
SCIATICA |
1 |
0.0001 |
| 97 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 98 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 99 |
GASTRIC DISORDER |
2 |
0.0001 |
| 100 |
MUSCULOSKELETAL PAIN |
3 |
0.0001 |
| 101 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 102 |
THIRST |
1 |
0.0001 |
| 103 |
ADVERSE DRUG REACTION |
5 |
0.0001 |
| 104 |
MYELOSUPPRESSION |
2 |
0.0001 |
| 105 |
FLATULENCE |
3 |
0.0001 |
| 106 |
HAEMORRHOIDS |
1 |
0.0001 |
| 107 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 108 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 109 |
ASTHENIA |
18 |
0.0000 |
| 110 |
MOUTH ULCERATION |
1 |
0.0000 |
| 111 |
CONDITION AGGRAVATED |
14 |
0.0000 |
| 112 |
BURNING SENSATION |
3 |
0.0000 |
| 113 |
MOBILITY DECREASED |
3 |
0.0000 |
| 114 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 115 |
UNDERDOSE |
3 |
0.0000 |
| 116 |
JOINT STIFFNESS |
1 |
0.0000 |
| 117 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 118 |
ABDOMINAL PAIN UPPER |
7 |
0.0000 |
| 119 |
INSOMNIA |
9 |
0.0000 |
| 120 |
IRRITABILITY |
2 |
0.0000 |
| 121 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 122 |
HYPERSENSITIVITY |
6 |
0.0000 |
| 123 |
RHINORRHOEA |
2 |
0.0000 |
| 124 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 125 |
BACK PAIN |
7 |
0.0000 |
| 126 |
RASH |
13 |
0.0000 |
| 127 |
MALAISE |
13 |
0.0000 |
| 128 |
PYREXIA |
10 |
0.0000 |
| 129 |
PRURITUS |
11 |
0.0000 |
| 130 |
FATIGUE |
21 |
0.0000 |
| 131 |
DYSGEUSIA |
2 |
0.0000 |
| 132 |
HOT FLUSH |
2 |
0.0000 |
| 133 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 134 |
COLITIS |
1 |
0.0000 |
| 135 |
ACNE |
2 |
0.0000 |
| 136 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 137 |
CHILLS |
3 |
0.0000 |
| 138 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 139 |
EMOTIONAL DISTRESS |
3 |
0.0000 |
| 140 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 141 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 142 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 143 |
HYPERHIDROSIS |
3 |
0.0000 |
| 144 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 145 |
HYPOKALAEMIA |
1 |
0.0000 |
| 146 |
NAUSEA |
17 |
0.0000 |
| 147 |
VOMITING |
10 |
0.0000 |
| 148 |
PAIN |
13 |
0.0000 |
| 149 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 150 |
MIGRAINE |
2 |
0.0000 |
| 151 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
4 |
0.0000 |
| 152 |
ILLNESS |
2 |
0.0000 |
| 153 |
PARAESTHESIA |
3 |
0.0000 |
| 154 |
OFF LABEL USE |
16 |
0.0000 |
| 155 |
DRUG INEFFECTIVE |
24 |
0.0000 |
| 156 |
ANXIETY |
5 |
0.0000 |
| 157 |
COVID-19 |
3 |
0.0000 |
| 158 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 159 |
HEADACHE |
10 |
0.0000 |
| 160 |
FEELING ABNORMAL |
3 |
0.0000 |
| 161 |
DIARRHOEA |
8 |
0.0000 |
| 162 |
TREATMENT FAILURE |
1 |
0.0000 |
| 163 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 164 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 165 |
ADVERSE EVENT |
1 |
0.0000 |
| 166 |
COUGH |
3 |
0.0000 |
| 167 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 168 |
FALL |
3 |
0.0000 |
| 169 |
DEPRESSION |
2 |
0.0000 |
| 170 |
DIZZINESS |
4 |
0.0000 |
| 171 |
NEUTROPENIA |
1 |
0.0000 |
| 172 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 173 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 174 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 175 |
TREMOR |
1 |
0.0000 |
| 176 |
MYALGIA |
1 |
0.0000 |
| 177 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 178 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 179 |
DYSPNOEA |
3 |
0.0000 |
| 180 |
OVERDOSE |
1 |
0.0000 |
| 181 |
CONSTIPATION |
1 |
0.0000 |
| 182 |
WEIGHT INCREASED |
1 |
0.0000 |
| 183 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |